IM Cannabis (IMCC) Non-Current Debt (2020 - 2025)
IM Cannabis' (IMCC) quarterly Non-Current Debt came in at $671192.8 in Q4 2025, up 101.21% year-on-year from $333585.7 in Q4 2024, and up 101.21% quarter-over-quarter from $333585.7 in Q4 2024.
IM Cannabis (IMCC) Non-Current Debt (2020 - 2025) Analysis & Trends
IM Cannabis' Non-Current Debt history runs 6 years deep, the most recent figure standing at $671192.8 for Q4 2025.
- On a quarterly basis, Non-Current Debt rose 101.21% year-over-year to $671192.8 in Q4 2025; TTM through Dec 2025 was $671192.8, a 101.21% increase from a year earlier, with the FY2025 full-year figure at $671192.8, up 97.2% from the prior year.
- Non-Current Debt rose to $671192.8 in Q4 2025 per IMCC's latest filing, from $333585.7 in the prior quarter.
- Across five years, Non-Current Debt topped out at $671192.8 in Q4 2025 and bottomed at $277656.6 in Q2 2022.
- The 5-year median for Non-Current Debt is $293944.5 (2022), against an average of $320010.5.
- Across the five-year window, Non-Current Debt jumped 2007.56% in 2021 and retreated 5.52% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $310987.7 in 2021, then retreated by 5.48% to $293944.5 in 2022, then declined by 1.54% to $289407.0 in 2023, then gained by 15.27% to $333585.7 in 2024, then surged by 101.21% to $671192.8 in 2025.
- Per Business Quant, the three latest IMCC Non-Current Debt figures stand at $671192.8 (Q4 2025), $333585.7 (Q4 2024), and $296886.6 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 671,192.76 |
| Dec 31, 2024 | 333,585.70 |
| Sep 30, 2024 | 296,886.63 |
| Jun 30, 2024 | 293,187.36 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | 289,407.00 |
| Sep 30, 2023 | 280,469.86 |
| Jun 30, 2023 | 282,147.48 |
| Mar 31, 2023 | 290,700.67 |
| Dec 31, 2022 | 293,944.47 |
| Sep 30, 2022 | 283,696.11 |
| Jun 30, 2022 | 277,656.59 |
| Mar 31, 2022 | 298,421.70 |
| Dec 31, 2021 | 310,987.74 |
| Sep 30, 2021 | 300,286.72 |
| Dec 31, 2020 | 14,755.83 |